Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
6.50
+0.12 (1.88%)
Nov 20, 2024, 4:00 PM EST - Market closed
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $202.39 million as of November 21, 2024. Its market cap has increased by 59.46% in one year.
Market Cap
202.39M
Enterprise Value
18.95M
1-Year Change
59.46%
Ranking
Category
Stock Price
$6.50
Market Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $202.39M, a decrease of -13.92%. That is a compound annual growth rate of -7.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 202.39M | 85.34% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neurogene | 210.50M |
| MacroGenics | 207.43M |
| Sera Prognostics | 205.00M |
| Inhibrx Biosciences | 204.83M |
| Molecular Partners AG | 204.67M |
| Personalis | 201.27M |
| Solid Biosciences | 199.97M |
| Lexeo Therapeutics | 199.39M |